Royal Bank of Canada’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.9M | Buy |
270,245
+129,299
| +92% | +$7.11M | ﹤0.01% | 1582 |
|
|
2025
Q1 | $9.96M | Buy |
140,946
+5,262
| +4% | +$372K | ﹤0.01% | 1565 |
|
|
2024
Q4 | $8.92M | Buy |
135,684
+70,303
| +108% | +$4.62M | ﹤0.01% | 1636 |
|
|
2024
Q3 | $4.6M | Sell |
65,381
-72,462
| -53% | -$5.09M | ﹤0.01% | 2071 |
|
|
2024
Q2 | $11.3M | Sell |
137,843
-5,518
| -4% | -$454K | ﹤0.01% | 1438 |
|
|
2024
Q1 | $12.5M | Sell |
143,361
-18,060
| -11% | -$1.58M | ﹤0.01% | 1377 |
|
|
2023
Q4 | $15.6M | Buy |
161,421
+2,430
| +2% | +$234K | ﹤0.01% | 1235 |
|
|
2023
Q3 | $14.1M | Sell |
158,991
-31,238
| -16% | -$2.76M | ﹤0.01% | 1190 |
|
|
2023
Q2 | $16.5M | Sell |
190,229
-25,117
| -12% | -$2.18M | ﹤0.01% | 1132 |
|
|
2023
Q1 | $20.9M | Buy |
215,346
+37,035
| +21% | +$3.6M | 0.01% | 987 |
|
|
2022
Q4 | $18.5M | Buy |
178,311
+11,815
| +7% | +$1.22M | 0.01% | 1060 |
|
|
2022
Q3 | $14.1M | Buy |
166,496
+10,654
| +7% | +$903K | ﹤0.01% | 1139 |
|
|
2022
Q2 | $12.9M | Buy |
155,842
+2,744
| +2% | +$227K | ﹤0.01% | 1242 |
|
|
2022
Q1 | $11.8M | Buy |
153,098
+35,791
| +31% | +$2.76M | ﹤0.01% | 1402 |
|
|
2021
Q4 | $10.4M | Buy |
117,307
+1,662
| +1% | +$147K | ﹤0.01% | 1592 |
|
|
2021
Q3 | $8.94M | Sell |
115,645
-30,102
| -21% | -$2.33M | ﹤0.01% | 1668 |
|
|
2021
Q2 | $12.2M | Buy |
145,747
+44,622
| +44% | +$3.72M | ﹤0.01% | 1513 |
|
|
2021
Q1 | $7.64M | Buy |
101,125
+14,044
| +16% | +$1.06M | ﹤0.01% | 1721 |
|
|
2020
Q4 | $7.64M | Sell |
87,081
-16,202
| -16% | -$1.42M | ﹤0.01% | 1654 |
|
|
2020
Q3 | $7.86M | Sell |
103,283
-17,128
| -14% | -$1.3M | ﹤0.01% | 1488 |
|
|
2020
Q2 | $14.9M | Buy |
120,411
+62,058
| +106% | +$7.66M | 0.01% | 1071 |
|
|
2020
Q1 | $4.93M | Buy |
58,353
+4,168
| +8% | +$352K | ﹤0.01% | 1576 |
|
|
2019
Q4 | $4.58M | Buy |
54,185
+8,961
| +20% | +$758K | ﹤0.01% | 1862 |
|
|
2019
Q3 | $3.05M | Buy |
45,224
+6,346
| +16% | +$428K | ﹤0.01% | 2037 |
|
|
2019
Q2 | $3.33M | Buy |
38,878
+6,138
| +19% | +$526K | ﹤0.01% | 2001 |
|
|
2019
Q1 | $2.91M | Sell |
32,740
-6,574
| -17% | -$584K | ﹤0.01% | 2034 |
|
|
2018
Q4 | $3.35M | Buy |
39,314
+2,512
| +7% | +$214K | ﹤0.01% | 1874 |
|
|
2018
Q3 | $3.57M | Sell |
36,802
-1,367
| -4% | -$133K | ﹤0.01% | 1994 |
|
|
2018
Q2 | $3.6M | Sell |
38,169
-11,893
| -24% | -$1.12M | ﹤0.01% | 1888 |
|
|
2018
Q1 | $4.06M | Buy |
50,062
+12,257
| +32% | +$994K | ﹤0.01% | 1799 |
|
|
2017
Q4 | $3.37M | Buy |
37,805
+3,472
| +10% | +$310K | ﹤0.01% | 1889 |
|
|
2017
Q3 | $3.2M | Sell |
34,333
-7,833
| -19% | -$729K | ﹤0.01% | 1879 |
|
|
2017
Q2 | $3.83M | Buy |
42,166
+2,066
| +5% | +$188K | ﹤0.01% | 1733 |
|
|
2017
Q1 | $3.52M | Buy |
40,100
+6,940
| +21% | +$609K | ﹤0.01% | 1783 |
|
|
2016
Q4 | $2.75M | Sell |
33,160
-4,771
| -13% | -$395K | ﹤0.01% | 1868 |
|
|
2016
Q3 | $3.51M | Buy |
37,931
+11,647
| +44% | +$1.08M | ﹤0.01% | 1720 |
|
|
2016
Q2 | $2.05M | Buy |
26,284
+2,332
| +10% | +$181K | ﹤0.01% | 2056 |
|
|
2016
Q1 | $1.98M | Sell |
23,952
-25,758
| -52% | -$2.12M | ﹤0.01% | 2050 |
|
|
2015
Q4 | $5.21M | Buy |
49,710
+3,752
| +8% | +$393K | ﹤0.01% | 1510 |
|
|
2015
Q3 | $4.84M | Buy |
45,958
+2,747
| +6% | +$289K | ﹤0.01% | 1311 |
|
|
2015
Q2 | $5.91M | Sell |
43,211
-8,827
| -17% | -$1.21M | ﹤0.01% | 1281 |
|
|
2015
Q1 | $6.49M | Sell |
52,038
-55,647
| -52% | -$6.93M | ﹤0.01% | 1227 |
|
|
2014
Q4 | $9.74M | Buy |
107,685
+5,153
| +5% | +$466K | 0.01% | 1039 |
|
|
2014
Q3 | $7.4M | Sell |
102,532
-9,683
| -9% | -$699K | 0.01% | 1152 |
|
|
2014
Q2 | $6.98M | Buy |
112,215
+61,731
| +122% | +$3.84M | ﹤0.01% | 1202 |
|
|
2014
Q1 | $3.44M | Buy |
50,484
+6,536
| +15% | +$446K | ﹤0.01% | 1561 |
|
|
2013
Q4 | $3.09M | Sell |
43,948
-189
| -0.4% | -$13.3K | ﹤0.01% | 1587 |
|
|
2013
Q3 | $3.19M | Buy |
44,137
+26,074
| +144% | +$1.88M | ﹤0.01% | 1532 |
|
|
2013
Q2 | $1.01M | Buy |
+18,063
| New | +$1.01M | ﹤0.01% | 2103 |
|